Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B27

RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230

これはPDB形式変換不可エントリーです。
7B27 の概要
エントリーDOI10.2210/pdb7b27/pdb
分子名称Surface glycoprotein, neutralizing nanobody NM1230, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
機能のキーワードsars-cov2, receptor binding domain, complex structure, neutralizing nanobody, viral protein
由来する生物種Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
詳細
タンパク質・核酸の鎖数4
化学式量合計81319.46
構造登録者
Ostertag, E.,Zocher, G.,Stehle, T. (登録日: 2020-11-26, 公開日: 2021-05-12, 最終更新日: 2024-10-16)
主引用文献Wagner, T.R.,Ostertag, E.,Kaiser, P.D.,Gramlich, M.,Ruetalo, N.,Junker, D.,Haering, J.,Traenkle, B.,Becker, M.,Dulovic, A.,Schweizer, H.,Nueske, S.,Scholz, A.,Zeck, A.,Schenke-Layland, K.,Nelde, A.,Strengert, M.,Walz, J.S.,Zocher, G.,Stehle, T.,Schindler, M.,Schneiderhan-Marra, N.,Rothbauer, U.
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.
Embo Rep., 22:e52325-e52325, 2021
Cited by
PubMed Abstract: In light of the COVID-19 pandemic, there is an ongoing need for diagnostic tools to monitor the immune status of large patient cohorts and the effectiveness of vaccination campaigns. Here, we present 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding domain (RBD), of which 8 Nbs potently inhibit the interaction of RBD with angiotensin-converting enzyme 2 (ACE2) as the major viral docking site. Following detailed epitope mapping and structural analysis, we select two inhibitory Nbs, one of which binds an epitope inside and one of which binds an epitope outside the RBD:ACE2 interface. Based on these, we generate a biparatopic nanobody (bipNb) with viral neutralization efficacy in the picomolar range. Using bipNb as a surrogate, we establish a competitive multiplex binding assay ("NeutrobodyPlex") for detailed analysis of the presence and performance of neutralizing RBD-binding antibodies in serum of convalescent or vaccinated patients. We demonstrate that NeutrobodyPlex enables high-throughput screening and detailed analysis of neutralizing immune responses in infected or vaccinated individuals, to monitor immune status or to guide vaccine design.
PubMed: 33904225
DOI: 10.15252/embr.202052325
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.902 Å)
構造検証レポート
Validation report summary of 7b27
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon